Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1997 Feb;81(2):154–162. doi: 10.1136/bjo.81.2.154

Increased expression of angiogenic growth factors in age-related maculopathy

M Kliffen 1, H Sharma 1, C Mooy 1, S Kerkvliet 1, P T V M de Jong 1
PMCID: PMC1722110  PMID: 9059252

Abstract

AIMS/BACKGROUND—The late stages of age-related maculopathy (ARM), especially neovascular macular degeneration (ARMD), can severely affect central vision and are the main cause of blindness in the elderly in the Western world. It has been shown that angiogenic growth factors are present in neovascular membranes in ARMD. However, it is not known if angiogenic growth factors play a role in the onset of neovascularisation.
METHODS—In order to elucidate the involvement of angiogenic growth factors in the initiation of neovascularisation in early stages of ARM, the expression patterns of VEGF, TGF-β, b-FGF, and PDGF-AA on 18 human maculae with ARM, and on 11 control specimens were investigated immunohistochemically.
RESULTS—A significantly increased expression of VEGF (p=0.00001) and TGF-β (p=0.019) was found in the retinal pigment epithelium (RPE) of maculae with ARM compared with control maculae. Furthermore, an increased expression of VEGF and PDGF was found in the outer nuclear layer of maculae with ARM.
CONCLUSION—These results demonstrate an increased expression of VEGF in the RPE, and in the outer nuclear layer in maculae with ARM, that could be involved in the pathogenesis of neovascular macular degeneration. Furthermore, enhanced TGF-β expression in the RPE cells of maculae with early stages of ARM was shown.



Full Text

The Full Text of this article is available as a PDF (329.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Light microscopic images of immunohistochemistry with anti-VEGF antibodies. (A) Typical example of VEGF expression in a control macula; VEGF is present in smooth muscle cells (short arrow) of choroidal blood vessels (C) and in some (long arrows) of the retinal pigment epithelial cells (rpe). (B) The expression of VEGF in the RPE is increased in ARM maculae in comparison with control maculae. (C) The outer nuclear layer (ONL) and basal laminar deposit (long arrows) show expression of VEGF in this macula with neovascular macular degeneration. The myofibroblast cells (small arrows) in the scar tissue (S) contain VEGF as well. (D) Expression of VEGF in a large drusen (D) with calcified bodies (open arrow) in an ARM macula. (E) Macrophages (long arrow) that have infiltrated Bruch's membrane (b) in a ARM macula show intense staining for VEGF. A monocyte (open arrow) shows VEGF expression as well. Original magnification × 400. 

Figure 2  .

Figure 2  

Open in a new tab

Light microscopic images of immunohistochemistry with anti-TGF-β (A and B), b-FGF (C), and PDGF-AA (D and E) antibodies. (A) Control maculae show TGF-β expression in smooth muscle cells (long arrow) and endothelial cells (short arrow) of choroidal blood vessels (C). The RPE shows only faint staining in most of the control maculae. (B) TGF-β expression is increased in the RPE of this typical ARM macula. Basal laminar deposit (long arrow) contains TGF-β as well. Note that the most prominent RPE staining is present on top of a drusen (open arrow) that itself shows no staining. (C) A typical example of an ARM macula that shows b-FGF expression in the RPE. (D) PDGF-AA expression in a macula with neovascular macular degeneration. The retina demonstrates PDGF-AA expression, whereas the retina in control maculae shows no staining at all. Note that the expression in the outer nuclear layer (ONL) is more prominent than in the inner nuclear layer (INL) and ganglion cell layer (G). (E) PDGF expression in a large drusen (D) in a macula with neovascular macular degeneration. S = scar tissue, b = Bruch's membrane. Original magnification × 400. 

Figure 3  .

Figure 3  

Open in a new tab

Comparison of the immunohistochemical expression of VEGF (A and B), TGF-β (C and D), b-FGF (E and F), and PDGF-AA (G and H) in RPE (A, C, E, G) and choroid (B, D, F, H) between control maculae and ARM maculae. PoAb = Polyclonal antibody.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamis A. P., Shima D. T., Yeo K. T., Yeo T. K., Brown L. F., Berse B., D'Amore P. A., Folkman J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1993 Jun 15;193(2):631–638. doi: 10.1006/bbrc.1993.1671. [DOI] [PubMed] [Google Scholar]
  2. Aiello L. P., Northrup J. M., Keyt B. A., Takagi H., Iwamoto M. A. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol. 1995 Dec;113(12):1538–1544. doi: 10.1001/archopht.1995.01100120068012. [DOI] [PubMed] [Google Scholar]
  3. Aiello L. P., Pierce E. A., Foley E. D., Takagi H., Chen H., Riddle L., Ferrara N., King G. L., Smith L. E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10457–10461. doi: 10.1073/pnas.92.23.10457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Amin R., Puklin J. E., Frank R. N. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3178–3188. [PubMed] [Google Scholar]
  5. Bird A. C., Bressler N. M., Bressler S. B., Chisholm I. H., Coscas G., Davis M. D., de Jong P. T., Klaver C. C., Klein B. E., Klein R. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995 Mar-Apr;39(5):367–374. doi: 10.1016/s0039-6257(05)80092-x. [DOI] [PubMed] [Google Scholar]
  6. Bird A. C. Bruch's membrane change with age. Br J Ophthalmol. 1992 Mar;76(3):166–168. doi: 10.1136/bjo.76.3.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bressler N. M., Bressler S. B., Fine S. L. Age-related macular degeneration. Surv Ophthalmol. 1988 May-Jun;32(6):375–413. doi: 10.1016/0039-6257(88)90052-5. [DOI] [PubMed] [Google Scholar]
  8. Brogi E., Winkles J. A., Underwood R., Clinton S. K., Alberts G. F., Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest. 1993 Nov;92(5):2408–2418. doi: 10.1172/JCI116847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Campochiaro P. A., Sugg R., Grotendorst G., Hjelmeland L. M. Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. Exp Eye Res. 1989 Aug;49(2):217–227. doi: 10.1016/0014-4835(89)90092-4. [DOI] [PubMed] [Google Scholar]
  10. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P. C., Pan Y. C., Olander J. V., Connolly D. T., Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990 Dec 1;172(6):1535–1545. doi: 10.1084/jem.172.6.1535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. D'Amato R. J., Adamis A. P. Angiogenesis inhibition in age-related macular degeneration. Ophthalmology. 1995 Sep;102(9):1261–1262. [PubMed] [Google Scholar]
  12. Faktorovich E. G., Steinberg R. H., Yasumura D., Matthes M. T., LaVail M. M. Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J Neurosci. 1992 Sep;12(9):3554–3567. doi: 10.1523/JNEUROSCI.12-09-03554.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ferrara N., Heinsohn H., Walder C. E., Bunting S., Thomas G. R. The regulation of blood vessel growth by vascular endothelial growth factor. Ann N Y Acad Sci. 1995 Mar 27;752:246–256. doi: 10.1111/j.1749-6632.1995.tb17435.x. [DOI] [PubMed] [Google Scholar]
  14. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 1992 Jun 5;267(16):10931–10934. [PubMed] [Google Scholar]
  15. Glaser B. M., Campochiaro P. A., Davis J. L., Jr, Sato M. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol. 1985 Dec;103(12):1870–1875. doi: 10.1001/archopht.1985.01050120104029. [DOI] [PubMed] [Google Scholar]
  16. Green W. R., Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993 Oct;100(10):1519–1535. doi: 10.1016/s0161-6420(93)31466-1. [DOI] [PubMed] [Google Scholar]
  17. Green W. R., McDonnell P. J., Yeo J. H. Pathologic features of senile macular degeneration. Ophthalmology. 1985 May;92(5):615–627. [PubMed] [Google Scholar]
  18. Ishigooka H., Aotaki-Keen A. E., Hjelmeland L. M. Subcellular localization of bFGF in human retinal pigment epithelium in vitro. Exp Eye Res. 1992 Aug;55(2):203–214. doi: 10.1016/0014-4835(92)90184-t. [DOI] [PubMed] [Google Scholar]
  19. Killingsworth M. C., Sarks J. P., Sarks S. H. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (Lond) 1990;4(Pt 4):613–621. doi: 10.1038/eye.1990.86. [DOI] [PubMed] [Google Scholar]
  20. Klein R., Klein B. E., Linton K. L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992 Jun;99(6):933–943. doi: 10.1016/s0161-6420(92)31871-8. [DOI] [PubMed] [Google Scholar]
  21. Kliffen M., Mooy C. M., Luider T. M., Huijmans J. G., Kerkvliet S., de Jong P. T. Identification of glycosaminoglycans in age-related macular deposits. Arch Ophthalmol. 1996 Aug;114(8):1009–1014. doi: 10.1001/archopht.1996.01100140217021. [DOI] [PubMed] [Google Scholar]
  22. Kliffen M., Mooy C. M., Luider T. M., de Jong P. T. Analysis of carbohydrate structures in basal laminar deposit in aging human maculae. Invest Ophthalmol Vis Sci. 1994 Jun;35(7):2901–2905. [PubMed] [Google Scholar]
  23. Kliffen M., de Jong P. T., Luider T. M. Protein analysis of human maculae in relation to age-related maculopathy. Lab Invest. 1995 Aug;73(2):267–272. [PubMed] [Google Scholar]
  24. LaVail M. M., Unoki K., Yasumura D., Matthes M. T., Yancopoulos G. D., Steinberg R. H. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11249–11253. doi: 10.1073/pnas.89.23.11249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Leschey K. H., Hackett S. F., Singer J. H., Campochiaro P. A. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990 May;31(5):839–846. [PubMed] [Google Scholar]
  26. Lopez P. F., Grossniklaus H. E., Lambert H. M., Aaberg T. M., Capone A., Jr, Sternberg P., Jr, L'Hernault N. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991 Dec 15;112(6):647–656. doi: 10.1016/s0002-9394(14)77270-8. [DOI] [PubMed] [Google Scholar]
  27. Lopez P. F., Sippy B. D., Lambert H. M., Thach A. B., Hinton D. R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996 Apr;37(5):855–868. [PubMed] [Google Scholar]
  28. Miller J. W., Adamis A. P., Shima D. T., D'Amore P. A., Moulton R. S., O'Reilly M. S., Folkman J., Dvorak H. F., Brown L. F., Berse B. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994 Sep;145(3):574–584. [PMC free article] [PubMed] [Google Scholar]
  29. Minchenko A., Bauer T., Salceda S., Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest. 1994 Sep;71(3):374–379. [PubMed] [Google Scholar]
  30. Ocrant I., Fay C. T., Parmelee J. T. Expression of insulin and insulin-like growth factor receptors and binding proteins by retinal pigment epithelium. Exp Eye Res. 1991 May;52(5):581–589. doi: 10.1016/0014-4835(91)90060-r. [DOI] [PubMed] [Google Scholar]
  31. Pe'er J., Shweiki D., Itin A., Hemo I., Gnessin H., Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995 Jun;72(6):638–645. [PubMed] [Google Scholar]
  32. Penfold P. L., Killingsworth M. C., Sarks S. H. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985;223(2):69–76. doi: 10.1007/BF02150948. [DOI] [PubMed] [Google Scholar]
  33. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem. 1994 Mar 4;269(9):6271–6274. [PubMed] [Google Scholar]
  34. Ramrattan R. S., van der Schaft T. L., Mooy C. M., de Bruijn W. C., Mulder P. G., de Jong P. T. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci. 1994 May;35(6):2857–2864. [PubMed] [Google Scholar]
  35. Reddy V. M., Zamora R. L., Kaplan H. J. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1995 Sep;120(3):291–301. doi: 10.1016/s0002-9394(14)72158-0. [DOI] [PubMed] [Google Scholar]
  36. Sarks J. P., Sarks S. H., Killingsworth M. C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) 1988;2(Pt 5):552–577. doi: 10.1038/eye.1988.106. [DOI] [PubMed] [Google Scholar]
  37. Sarks S. H. Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol. 1976 May;60(5):324–341. doi: 10.1136/bjo.60.5.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sheraidah G., Steinmetz R., Maguire J., Pauleikhoff D., Marshall J., Bird A. C. Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology. 1993 Jan;100(1):47–51. doi: 10.1016/s0161-6420(13)31712-6. [DOI] [PubMed] [Google Scholar]
  39. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992 Oct 29;359(6398):843–845. doi: 10.1038/359843a0. [DOI] [PubMed] [Google Scholar]
  40. Sivalingam A., Kenney J., Brown G. C., Benson W. E., Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1990 Jun;108(6):869–872. doi: 10.1001/archopht.1990.01070080113046. [DOI] [PubMed] [Google Scholar]
  41. Sporn M. B., Roberts A. B., Wakefield L. M., de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987 Sep;105(3):1039–1045. doi: 10.1083/jcb.105.3.1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tanihara H., Yoshida M., Matsumoto M., Yoshimura N. Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1993 Feb;34(2):413–419. [PubMed] [Google Scholar]
  43. Vingerling J. R., Dielemans I., Bots M. L., Hofman A., Grobbee D. E., de Jong P. T. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol. 1995 Aug 15;142(4):404–409. doi: 10.1093/oxfordjournals.aje.a117648. [DOI] [PubMed] [Google Scholar]
  44. Vingerling J. R., Dielemans I., Hofman A., Grobbee D. E., Hijmering M., Kramer C. F., de Jong P. T. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995 Feb;102(2):205–210. doi: 10.1016/s0161-6420(95)31034-2. [DOI] [PubMed] [Google Scholar]
  45. Vinores S. A., Küchle M., Mahlow J., Chiu C., Green W. R., Campochiaro P. A. Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol. 1995 Nov;147(5):1289–1297. [PMC free article] [PubMed] [Google Scholar]
  46. Wahl S. M., Hunt D. A., Wakefield L. M., McCartney-Francis N., Wahl L. M., Roberts A. B., Sporn M. B. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5788–5792. doi: 10.1073/pnas.84.16.5788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yoshida M., Tanihara H., Yoshimura N. Platelet-derived growth factor gene expression in cultured human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1992 Nov 30;189(1):66–71. doi: 10.1016/0006-291x(92)91526-v. [DOI] [PubMed] [Google Scholar]
  48. van der Schaft T. L., Mooy C. M., de Bruijn W. C., Bosman F. T., de Jong P. T. Immunohistochemical light and electron microscopy of basal laminar deposit. Graefes Arch Clin Exp Ophthalmol. 1994 Jan;232(1):40–46. doi: 10.1007/BF00176436. [DOI] [PubMed] [Google Scholar]
  49. van der Schaft T. L., Mooy C. M., de Bruijn W. C., Oron F. G., Mulder P. G., de Jong P. T. Histologic features of the early stages of age-related macular degeneration. A statistical analysis. Ophthalmology. 1992 Feb;99(2):278–286. doi: 10.1016/s0161-6420(92)31982-7. [DOI] [PubMed] [Google Scholar]
  50. van der Schaft T. L., de Bruijn W. C., Mooy C. M., Ketelaars D. A., de Jong P. T. Element analysis of the early stages of age-related macular degeneration. Arch Ophthalmol. 1992 Mar;110(3):389–394. doi: 10.1001/archopht.1992.01080150087034. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES